Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 376.55 INR 0.7% Market Closed
Market Cap: 246.6B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Natco Pharma Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Natco Pharma Ltd
Gross Profit Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Natco Pharma Ltd
NSE:NATCOPHARM
Gross Profit
â‚ą35.2B
CAGR 3-Years
33%
CAGR 5-Years
16%
CAGR 10-Years
21%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Gross Profit
â‚ą205B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Gross Profit
â‚ą177.7B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Gross Profit
â‚ą398.2B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Gross Profit
â‚ą84.8B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
10%
M
Mankind Pharma Ltd
NSE:MANKIND
Gross Profit
â‚ą69.4B
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Natco Pharma Ltd's Gross Profit?
Gross Profit
35.2B INR

Based on the financial report for Jun 30, 2024, Natco Pharma Ltd's Gross Profit amounts to 35.2B INR.

What is Natco Pharma Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
21%

Over the last year, the Gross Profit growth was 54%. The average annual Gross Profit growth rates for Natco Pharma Ltd have been 33% over the past three years , 16% over the past five years , and 21% over the past ten years .

Back to Top